Granulosa Cells are integral components of ovarian follicles, playing a crucial role in the regulation of female reproductive processes. These specialized cells are found within the ovarian follicles, which are structures that house developing eggs (oocytes). Granulosa cells surround and nurture the oocyte, forming a layer known as the cumulus oophorus. They provide essential support for oocyte development by facilitating nutrient exchange and hormonal signaling. Granulosa cells respond to follicle-stimulating hormone (FSH) and luteinizing hormone (LH) produced by the pituitary gland, orchestrating follicular growth, ovulation, and the formation of the corpus luteum. During the menstrual cycle, granulosa cells undergo changes in response to hormonal fluctuations, contributing to the dynamic ovarian environment. Dysfunction in granulosa cell function can lead to fertility issues, polycystic ovary syndrome (PCOS), and other reproductive disorders. Research on granulosa cells is pivotal for understanding ovarian physiology, optimizing assisted reproductive technologies, and developing targeted therapies for reproductive health. The intricate interactions between granulosa cells, oocytes, and hormonal signaling pathways continue to be a focus of investigation, contributing to advancements in reproductive medicine and infertility treatments.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Stem cell technologies to integrate biodesign related tissue engineering within the frame of cell based regenerative medicine: towards the preventive therapeutic and rehabilitative resources and benefits
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : In vitro evaluation of lyophilized Dedifferentiated Fat cells (DFAT) impregnated artificial dermis
Kazutaka Soejima, Nihon University, School of Medicine, Japan
Title :
Nagy Habib, Imperial College London, United Kingdom
Title :
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : The regenerative medicine of the future
Marco Polettini, DVM, Italy